MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$4,502K
EPS
-$0.66
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
Research and development
2,840
1,659
General and administrative
1,610
2,136
Total operating expenses
4,450
3,795
Loss from operations
-4,450
-3,795
Other expense, net
-52
41
Net loss
-4,502
-3,754
Basic EPS
-0.66
-0.08
Diluted EPS
-0.66
-0.08
Basic Average Shares
6,789,165
48,210,071
Diluted Average Shares
6,789,165
48,210,071
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$4,502K
Loss from operations
-$4,450K
Other expense, net
-$52K
Total operating
expenses
$4,450K
Research and development
$2,840K
General and
administrative
$1,610K
Buy us a coffee
Eloxx Pharmaceuticals, Inc. (ELOX)
Eloxx Pharmaceuticals, Inc. (ELOX)